LMAO. I was actually referring to the almost 100% failure rate of melanocortin analogue drugs over the past 50 years due to severe side effects.
Punters here seem totally unaware that orphan drugs for diseases like EPP have much lower safety and efficacy requirements.
Bitopertin was originally developed by Roche as an antipsychotic. While it had an excellent safety profile it wasn't effective in treating schizophrenia.
- Forums
- ASX - By Stock
- CUV
- Ann: Appendix 4E and Annual Report 2022
Ann: Appendix 4E and Annual Report 2022, page-21
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$14.64 |
Change
0.060(0.41%) |
Mkt cap ! $731.6M |
Open | High | Low | Value | Volume |
$14.61 | $14.99 | $14.40 | $641.8K | 44.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 100 | $14.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.63 | 86 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 100 | 14.610 |
7 | 796 | 14.600 |
2 | 179 | 14.590 |
1 | 89 | 14.580 |
1 | 89 | 14.570 |
Price($) | Vol. | No. |
---|---|---|
14.630 | 86 | 5 |
14.640 | 112 | 4 |
14.650 | 90 | 1 |
14.660 | 311 | 6 |
14.670 | 240 | 3 |
Last trade - 12.09pm 10/07/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online